Quarterly report pursuant to Section 13 or 15(d)

Deferred Debt Issuance Costs

v3.24.1.1.u2
Deferred Debt Issuance Costs
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Deferred Debt Issuance Costs Deferred Debt Issuance Costs
Deferred debt issuance costs consist of the following (in thousands):
March 31,
2024		 December 31,
2023
Standing letter of credit $ 150  $ 150 
Equity letter of credit 554  554 
Line of credit $ 9,943  9,943 
Total 10,647  10,647 
Accumulated amortization (10,285) (9,341)
Deferred debt issuance costs $ 362  $ 1,306 
SLOC
For the three months ended March 31, 2024 and 2023, the Company recognized amortization expense of approximately $0.8 million and $41,000, respectively.
Equity line of credit
In July 2023, the Company entered into the equity line of credit (“ELOC”) for the right to sell common stock shares to an investor and recorded deferred debt issuance costs of approximately $0.6 million. For the three months ended March 31, 2024, the Company recognized amortization expense of approximately $0.1 million.
Line of Credit
During the three months ended March 31, 2024, in connection with the $2.4 million draw down and issuance of the convertible promissory notes, the Company recognized amortization expense of approximately $0.9 million. During the three months ended March 31, 2023, the Company recognized amortization expense of approximately $1.8 million.